Literature DB >> 9188099

A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.

M Muramatsu1, J Yan, K Eto, T Tomoda, R Yamada, K Arai.   

Abstract

Receptor-type serine/threonine kinases (RSKs) have been organized into two distinct classes known as types I and II on the basis of sequence similarity. However, experiments have shown ligand specificities in the two classes and as a result type I and type II receptors can often bind to a common ligand. The transforming growth factor-beta- (TGF-beta) specific receptors represent such a case, where both type I and II receptors (T beta RI and T beta RII) are observed. Of additional interest is the observation that heteromeric associations of type I and II receptors can also enable signaling. To further elucidate the function of various RSKs, the extracellular domains of both alpha and beta chains from human granulocyte-macrophage colony-stimulating factor receptors were linked to transmembrane cytoplasmic domains of RSKs. Chimeric receptors of human granulocyte-macrophage receptor (hGMR) alpha with T beta RI and hGMR beta with T beta RII were expressed in murine pre-B cell-derived Ba/F3 cells. These chimeras formed heteromeric complexes, transmitted TGF-beta signals, and were down-modulated in response to human granulocyte-macrophage colony-stimulating factor. However, experiments utilizing these chimeric receptors in different combinations revealed that only heteromeric associations of transmembrane cytoplasmic domains mediated signaling and down-modulation. Chimeric receptors with transmembrane cytoplasmic domains of activin receptor type II and bone morphogenetic protein receptor type II also provided signals in conjunction with chimeric T beta RI. As a result, these type II receptors may share a common potential to signal via T beta RI. hGMR-RSK chimeric receptors may be useful tools for the identification and characterization of the divergent signals mediated by individual RSKs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188099      PMCID: PMC276098          DOI: 10.1091/mbc.8.3.469

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  52 in total

1.  Homomeric interactions between type II transforming growth factor-beta receptors.

Authors:  R H Chen; R Derynck
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

2.  Identification of receptors for type-beta transforming growth factor.

Authors:  J Massagué
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

Authors:  R Ebner; R H Chen; L Shum; S Lawler; T F Zioncheck; A Lee; A R Lopez; R Derynck
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

4.  Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

Authors:  H Yamashita; P ten Dijke; P Franzén; K Miyazono; C H Heldin
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

5.  Cloning of an isoform of mouse TGF-beta type II receptor gene.

Authors:  A Suzuki; N Shioda; T Maeda; M Tada; N Ueno
Journal:  FEBS Lett       Date:  1994-11-21       Impact factor: 4.124

6.  Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction.

Authors:  T Okadome; H Yamashita; P Franzén; A Morén; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

7.  Mechanism of activation of the TGF-beta receptor.

Authors:  J L Wrana; L Attisano; R Wieser; F Ventura; J Massagué
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

8.  A low affinity chimeric human alpha/beta-granulocyte-macrophage colony-stimulating factor receptor induces ligand-dependent proliferation in a murine cell line.

Authors:  M Eder; T J Ernst; A Ganser; P T Jubinsky; R Inhorn; D Hoelzer; J D Griffin
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

9.  Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.

Authors:  B B Koenig; J S Cook; D H Wolsing; J Ting; J P Tiesman; P E Correa; C A Olson; A L Pecquet; F Ventura; R A Grant
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

10.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  5 in total

1.  Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Authors:  Sumedha G Penheiter; Hugh Mitchell; Nandor Garamszegi; Maryanne Edens; Jules J E Doré; Edward B Leof
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

2.  Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor.

Authors:  N Garamszegi; J J Doré; S G Penheiter; M Edens; D Yao; E B Leof
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

3.  Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.

Authors:  L Gilboa; A Nohe; T Geissendörfer; W Sebald; Y I Henis; P Knaus
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

4.  Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.

Authors:  F Biasi; L Tessitore; D Zanetti; J C Cutrin; B Zingaro; E Chiarpotto; N Zarkovic; G Serviddio; G Poli
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

5.  Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors.

Authors:  R A Anders; S L Arline; J J Doré; E B Leof
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.